Alphyn Biologics Reports Positive Pediatric Results from Phase 2a Atopic Dermatitis Trial

Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced positive results today from the pedia...

May 05, 2023 | Friday | News
Galmed Pharmaceuticals forms a Strategic Partnership with OnKai

OnKai, a US-based technology company, combines public healthcare and medical innovation experience with complex process digitalization, design thinking, an...

May 05, 2023 | Friday | News
Hansa Biopharma, Genethon Collaborate on Imlifidase Pre-Treatment for Crigler-Najjar Syndrome Patients with Anti-AAV Antibodies

The collaboration will, in a clinical study, evaluate the safety and efficacy of Hansa's antibody cleaving enzyme imlifidase as a pre-treatment prior ...

April 28, 2023 | Friday | News
Aditum Bio Announces Formation of Vitalli Bio, Focused on Immunological Disorders

Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical...

April 28, 2023 | Friday | News
MGI and South Australian Genomics Centre Introduce DNBSEQ-T7* to Supercharge Genomics Research in Australia

Located in the prestigious SAHMRI building in Adelaide, SAGC is a nationally accredited genomics facility that supports research nationally and internation...

April 27, 2023 | Thursday | News
AmerisourceBergen Launches Cell and Gene Therapy Integration Hub

-AmerisourceBergen, a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integr...

April 26, 2023 | Wednesday | News
Agilent and Theragen Bio collaborate to boost cancer genomic profiling through bioinformatic solutions in South Korea.

Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to boos...

April 26, 2023 | Wednesday | News
Merck introduces Ultimus® Film for enhanced strength and leak resistance in single-use assemblies.

Cutting-edge technology now available in Mobius® 3D process containers Provides 10 times greater abrasion resistance compared to other single-use bi...

April 26, 2023 | Wednesday | News
Trust Your Gut: Balancing the Microbiome for Better Health

A balanced microbiome plays an important role in maintaining human health by promoting protective immune responses and limiting excessive inflammation. But...

April 25, 2023 | Tuesday | News
Forge Biologics Receives QP Declaration for AAV Gene Therapy Manufacturing in Europe

Forge Biologics, a leading manufacturer of genetic medicines, today announced that its manufacturing facility has successfully completed the audits necessa...

April 24, 2023 | Monday | News
Aurisco Expands Oligonucleotide Capacity and Launches New Website

The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial olig...

April 24, 2023 | Monday | News
Janux Therapeutics Announces First Patient Dosed with JANX008 in First-in-Human Phase 1 Clinical Trial in Patients with Solid Tumors

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applyin...

April 21, 2023 | Friday | News
Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Announced an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) (NCT045...

April 19, 2023 | Wednesday | News
South Korean Biotech, ToolGen Leads the Development of Numerous Cutting-Edge Genome Editing Techniques

The first study presents a new cell-based assay called TAgmentation of Prime Editor sequencing (TAPE-seq) that can predict genome-wide off-target candidate...

April 19, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close